Heart mitochondrial dysfunction in diabetic rats

Biocell

Volumn 40, Issue 1, 2016, Pages 7-10

  Bombicino, Silvina S ^a   Iglesias, Darío E ^a   Rukavina Mikusic, Ivana A ^a   Boveris, Alberto ^a   Valdez, Laura B ^a  

^a NONE

Author keywords

Diabetes; Diabetic cardiomyopathy; Heart; Mitochondria; Nitric oxide

Indexed keywords

ADENOSINE TRIPHOSPHATE; CYTOCHROME C OXIDASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ARTICLE; BETA ADRENERGIC STIMULATION; BIOSYNTHESIS; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIABETIC CARDIOMYOPATHY; DIABETIC PATIENT; DISEASE ASSOCIATION; DISEASE COURSE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENERGY METABOLISM; ENZYME ACTIVITY; HEART CONTRACTION; HEART MITOCHONDRION; HEART MUSCLE METABOLISM; HEART MUSCLE OXYGEN CONSUMPTION; HEART VENTRICLE FAILURE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; MITOCHONDRIAL BIOGENESIS; MITOCHONDRIAL RESPIRATION; NONHUMAN; RESPIRATION CONTROL; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TISSUE HOMOGENATE;

EID: 84992046636     PISSN: 03279545     EISSN: 16675746     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. American Diabetes Association (2008). Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 31: 555-560.
2. Aon MA, Tocchetti CG, Bhatt N, Paolocci N, Cortassa S, (2015). Protective Mechanisms of Mitochondria and Heart Function in Diabetes. Antioxidants and Redox Signaling 22: 1563-1586.
3. Bell DS. (2003) Diabetic cardiomyopathy. Diabetes Care 26: 2949–2951.
4. Boudina S, Dale Abel E (2007). Diabetic cardiomyopathy Revisited. Circulation 115: 3213-3223.
5. Chen Z, Siu B, Ho YS, Vincent R, Chua CC, Hamdy RC, Chua BH (1998). Overexpression of MnSOD protects against myocardial ischemia/reperfusion injury in transgenic mice. Journal of Molecular Cell Cardiology 30: 2281–2289.
6. Christians ES, Benjamin IJ (2012). Proteostasis and REDOX state in the heart. American journal of physiology. Heart and circulatory physi-ology 302: H24–H37.
7. Fein FS. (1990) Diabetic cardiomyopathy. Diabetes Care 13: 1169-1179.
8. Ferreira FM, Palmeira CM, Seica R, Moreno AJ, Santos MS (2003). Diabetes and mitochondrial bioenergetics: alterations with age. Journal of biochemical toxicology 17: 214–222.
9. Giulivi C, Poderoso JJ, Boveris A (1998). Production of nitric oxide by mitochondria, Journal of Biological Chemistry 273: 11038–11043.
10. Hambly RI, Zoneraich S, Sherman L (1974). Diabetic Cardiomyopathy. Journal of the American Medical Association 229: 1749-1754.
11. Khanna S, Bir Singh G, Khullar M (2014). NOS and diabetic cardiomyopathy. Nitric Oxide 43: 29-34
12. Navarro A, Torrejon R, Bandez MJ, Lopez-Cepero JM, Boveris A (2005). Mitochondrial function and mitochondria-induced apoptosis in an overstimulated rat ovarian cycle, American journal of physiology. Endocrinology and metabolism 289: E1101–1109.
13. Neubauer S (2007). The failing heart-an engine out of fuel. New England Journal of Medicine 365: 1140-1151.
14. Pacher P, Szabó C (2006). Role of peroxinitrite in the pathogenesis of cardiovascular complications of diabetes. Current Opinion in Pharma-cology 6: 136-141
15. Pierce GN, Dhalla NS (1985). Heart mitochondrial function in chronic experimental diabetes in rats. The Canadian Journal of Cardiology 1: 48–54.
16. Rajesh M, Mukhopadhyay P, Bátkai S, Mukhopadhyay B, Patel V, Haskó G, Szabó C, Mabley JG, Liaudet L, Pacher P. (2009). XO inhibitor allopurinol attenuates the development of diabetic cardiomyopathy. Journal of medicine and biochemistry 13: 2330-2341
17. Rajesh M, Bátkai S, Kechrid M, Mukhopadhyay P, Lee WS, Horváth B, Holovac E, Cinar R, Liaudet L, Mackie K, Haskó G and Pacher P (2012). Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflamation, and fibrosis in diabetic cardiomyopathy. Diabetes 61: 716-727.
18. Rolo A, Palemira C, (2006). Diabetes and mitochondrial function: Role of hyperglycemia and ox stress. Toxicology and Applied pharmacology 212: 167-178.
19. Smith JM, Paulson DJ, Romano FD (1997). Inhibition of Nitric Oxide Synthase by L.NAME improves ventricular performance in STZ-dia-betic rats. Journal of molecular and cellular cardiology 29: 2393-2404
20. Stockklauser-Färber K, Ballhausen T, Laufer A, Rösen P (2000). Influence of diabetes on cardiac nitric oxide synthase expression and activity. Biochimica et Biophysica Acta 1535: 10-20.
21. Valdez LB, Zaobornyj T, Boveris A (2006). Mitochondrial metabolic states and membrane potential modulate mtNOS activity. Biochimemical et Biophysical Acta 1757: 166–172.
22. Valdez LB, Boveris A (2007). Mitochondrial nitric oxide synthase, a voltage-dependent enzyme, is responsible for nitric oxide diffusion to cytosol, Frontiers in Bioscience 12: 1210–1219.
23. Valdez LB, Zaobornyj T, Bombicino S, Iglesias DE, Boveris A, Donato M, D’Annunzio V, Bucholz B, Gelpi RJ (2011). Complex I syndrome in myocardial stunning and the effect of adenosine. Free Radical Biology and Medicine 51: 1203-1212.
24. Vanasco V, Saez T, Magnani ND, Pereyra L, Marchini T, Corach A, Vaccaro MI, Corach D, Evelson P, Alvarez S. (2014). Cardiac mitochondrial biogenesis in endotoxemia is not accompanied by mitochondrial function recovery. Free Radical Biology and Medicine 77: 1-9.
25. Varga ZV, Giricz Z, Liaudet L, Haskó G, Ferdinandy P, PacherP (2015). Interplay of oxidative, nitrosative/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathy. Biochimica et biophysica acta 1852: 232-42.
26. Zaobornyj T, Valdez LB, Iglesias DE, Gasco M, Gonzales GF, Boveris A (2009). Mitochondrial nitric oxide metabolism during rat heart adaptation to high altitude: effect of sildenafil, L-NAME, and L-arginine treatments. American journal of physiology. Heart and circulatory physiology 296: H1741–7.
27. Zaobornyj T, Ghafourifar P (2012). Strategic localization of heart mitochondrial NOS: a review of the evidence. American Journal of Physiology-Heart Circulatory Physiology 303: 1283-1293.